NEW YORK (GenomeWeb News) – MolecularHealth today announced its US clinical laboratory has been CLIA-certified.

With the certification, the Woodlands, Texas-based facility will begin offering two tests. One is a targeted gene panel of more than 500 known cancer genes, and the other offers whole-exome sequencing of the tumor genome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.